A Study to Evaluate the Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Englumafusp Alfa in Combination With Obinutuzumab and in Combination With Glofitamab Following a Pre-Treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma

计划入组 498 人 · 首次发布于 2019 年 9 月 4 日

Clinical Biomarkers in Alpha-mannosidosis

计划入组 11 人 · 首次发布于 2014 年 5 月 19 日

International Registry of Patients With Alpha Thalassemia

计划入组 500 人 · 首次发布于 2021 年 5 月 4 日

Englumafusp alfa

ALPHA-0602

Alpha-101

Alpha Metallurgical

United States

Zeno Alpha, Inc.

United States

Alpha Republic GmbH

Austria

Novel Bispecific Antibody Combinations Show Promise in Indolent Lymphoma Treatment

Alpha Tau Secures MDSAP Certification for Alpha DaRT Cancer Therapy Manufacturing Facility

Alpha Tau Initiates First U.S. Patient Treatment in Pancreatic Cancer Trial Combining Alpha DaRT with Chemotherapy